COPD Spotlight

Antonio Anzueto, MD, recently spoke with The American Journal of Managed Care® (AJMC®) about some of the latest developments in chronic obstructive pulmonary disease (COPD). Anzueto is a professor of medicine and section chief of pulmonary at South Texas Veterans Healthcare System, an affiliated institution with the University of Texas Health San Antonio, Texas.

Antonio Anzueto, MD, recently spoke with The American Journal of Managed Care® (AJMC®) about the latest advances in therapy for chronic obstructive pulmonary disease (COPD), as well as what is known about the relationship between COPD and cardiovascular disease. Anzueto is a professor of medicine and section chief of pulmonary at South Texas Veterans Healthcare System, an affiliated institution with the University of Texas Health San Antonio, Texas.

In this interview, Sanjay Sethi, MD, professor and chief, Pulmonary, Critical Care and Sleep Medicine; assistant vice president for Health Sciences, Department of Medicine, Jacobs School of Medicine & Biomedical Sciences, Buffalo, New York, discusses the complications of managing patients with multiple comorbidities that are not preventable.

There is a need for continuous education for patients and providers in order to better diagnose and manage chronic obstructive pulmonary disease (COPD), according to Sanjay Sethi, MD, professor and chief, Pulmonary, Critical Care and Sleep Medicine; assistant vice president for Health Sciences, Department of Medicine, Jacobs School of Medicine & Biomedical Sciences, Buffalo, New York,

Fernando Martinez, MD, MS, chief of the Pulmonary and Critical Care Medicine Division, Weill Cornell Medicine, New York, continues a conversation about the updates in the 2023 Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (COPD).

In this interview, Fernando Martinez, MD, MS, chief of the Pulmonary and Critical Care Medicine Division, Weill Cornell Medicine, New York, discusses the 2023 Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (COPD).

The therapies to treat chronic obstructive pulmonary disease (COPD) include devices with instructions for use, which are far more complicated than simply smoking a cigarette.

There are various treatments on the market for patients with chronic obstructive pulmonary disease (COPD), all with their own pros and cons to be considered as part of a personalized treatment regimen.

Respiratory therapist Michael Hess, MPH, RRT, RPFT, discusses the main therapies used for chronic management of chronic obstructive pulmonary disorder (COPD), as well as the decision to escalate to triple therapy.

Nicola Hanania, MD, MS, discusses the future of research on triple therapy and chronic obstructive pulmonary disease (COPD).

Julia Slejko, PhD, and Robert Reed, MD, discuss findings of their recent study on patient-reported value in chronic obstructive pulmonary disease (COPD) treatment management.

Trisha Parekh, DO, discusses her research on the impact of psychological stress on low-income patients with chronic obstructive pulmonary disease (COPD).

Gerard Criner, MD, FACP, FACCP, offers insights on the next steps for triple therapy, challenges of early COPD diagnosis, and how the pandemic could impact long-term lung health.

Anzueto, a professor of medicine at the University of Texas Health in San Antonio and clinician practicing pulmonary and clinical care, also serves as a member of the GOLD Science Committee.

Meilan King Han, MD, a professor of internal medicine at the University of Michigan, discusses how her practice has altered patient care to adapt to the ongoing pandemic and challenges patients with chronic obstructive pulmonary disease (COPD) and providers face when dealing with a highly contagious airborne respiratory virus.